Guardian Pharmacy Services, Inc.

Guardian Pharmacy Services, Inc. (NYSE: GPS) operates as a leading pharmacy services company providing technology-enabled pharmaceutical and clinical services to long-term care facilities across the United States. The company's website is www.guardianpharmacy.com.

Guardian specializes in serving assisted living facilities, behavioral health facilities, group homes, and skilled nursing facilities by delivering comprehensive medication management solutions tailored to the complex needs of residents with multiple chronic conditions and intricate drug regimens. As of December 31, 2025, the company operated 61 pharmacies, 54 of which are full-service locations, serving approximately 205,000 residents across roughly 8,400 long-term care facilities in 38 states. More than two-thirds of annual revenue derives from assisted living facilities and behavioral health facilities, which represent the company's primary target markets.

The company's service portfolio includes compliance packaging, robotic dispensing automation, electronic medication administration record integration, pharmacist consultation services, medication therapy management, antibiotic stewardship programs, and psychotropic medication optimization. Guardian operates a proprietary centralized data warehouse supporting its Guardian Compass operational platform and GuardianShield clinical analytics suite, which deliver real-time dashboards and actionable insights to enhance pharmacy operations and resident outcomes.

Guardian's business model combines local pharmacy autonomy with centralized corporate support across technology, purchasing, revenue cycle management, regulatory compliance, and business development functions. The company maintains relationships with major pharmaceutical wholesalers including Cardinal Health, McKesson Corporation, and others, and derives approximately 71 percent of revenues from Medicare Part D reimbursement, with the remainder from Medicaid, commercial plans, and other sources. No single customer represents more than 10 percent of consolidated revenues.

The company holds approximately 13 percent market share nationally in assisted living and memory care facilities based on prescription volume data. Guardian's competitive positioning reflects its purpose-built infrastructure, clinical expertise, technology investments, and focus on higher-acuity assisted living and behavioral health markets where residents typically maintain pharmacy choice rights and require sophisticated medication coordination services.